FindTrial
Sign In

comparison of two adjuvant drugs to prolong spinal anaesthesia

A Comparison between Intrathecal Nalbuphine and Intrathecal Dexmedetomidine as adjuvant to 0.5% hyperbaric bupivacaine for orthopedic surgery of lower limbs under Sub Arachnoid Block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045923
Enrollment
60
Registered
2022-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: spinal anaesthesia: spinal anaesthesia for orthopedic lower limb surgeries with bupivacaine and either nalbuphine or dexmedetomidine as adjuvant Control Intervention1: subarachnoid bloc

Sponsors

JNUIMSRC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and 2

Exclusion criteria

Exclusion criteria: Bleeding diathesis local infection severe systemic diseases spinal deformities and surgery not willing to give consent

Design outcomes

Primary

MeasureTime frame
onset of sensory and motor blocks duration of sensory and motor blocks duration of analgesiaTimepoint: onset of sensory and motor blocks at 2, 4, 6, and 8 minutes Duration of analgesia at 2, 3, 4, and 5 hours duration of sensory and motor blocks at 60, 90, 120, 150, and 180 minutes duration of analgesia—

Secondary

MeasureTime frame
any side effectsTimepoint: every 30 minutes—

Countries

India

Contacts

Public ContactDr Geetanjali Singhal

Jaipur National University Institute For Medical Sciences and Research Centre

singhalgeetanjali@yahoo.com9829051344

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026